[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for Medical Devices; Device Tracking 21 CFR Pa...[ Price : $8.95]
FDA medical reviewers give a generally positive assessment of Biogens aducanumab that is indicated to delay clinical decline in pa...[ Price : $8.95]
FDA releases an FDA-483 with five observations from an inspection at STAQ Pharma.[ Price : $8.95]
FDA and the generic drug industry each offer proposals to advance quicker ANDA approvals.[ Price : $8.95]
Researchers say there is a correlation between medical device company payments to doctors and the selection of defibrillator devic...[ Price : $8.95]
Bristol Myers Squibb announces positive results from POETYK PSO-1, a pivotal Phase 3 trial evaluating deucravacitinib, a novel, or...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include Cosmax USA and Immusist LLC.[ Price : $8.95]
FDA authorizes the de novo marketing of Tandem Diabetes Cares Control-IQ Technology, an interoperable automated glycemic controlle...